Top

Published in:

01-08-2012 | Clinical Trial

Impact of real-time virtual sonography, a coordinated sonography and MRI system that uses an image fusion technique, on the sonographic evaluation of MRI-detected lesions of the breast in second-look sonography

Authors: Shogo Nakano, Junko Kousaka, Kimihito Fujii, Kyoko Yorozuya, Miwa Yoshida, Yukako Mouri, Miwa Akizuki, Rie Tetsuka, Takahito Ando, Takashi Fukutomi, Yukihiko Oshima, Junko Kimura, Tsuneo Ishiguchi, Osamu Arai

Published in: Breast Cancer Research and Treatment | Issue 3/2012

Abstract

The aim of this study was to verify the utility of second-look sonography using real-time virtual sonography (RVS)—a coordinated sonography with an MRI system that uses an image fusion technique with magnetic navigation—on the sonographic evaluation of MRI-detected lesions of the breast. Of the 196 consecutive patients who were examined with breast MRI in our hospital from 2006 to 2009, those patients who underwent second-look sonography to identify MRI-detected lesions were enrolled in this study. MRI was performed using a 1.5-T imager with the patient in a supine position. To assess the efficacy benefits of RVS, the correlations between lesion detection rates, MRI features, distribution, and histopathological classification on second-look sonography using conventional B-mode or RVS were analyzed. Of the 196 patients, 55 (28 %) demonstrated 67 lesions initially detected by MRI, followed by second-look sonography. Of the 67 MRI-detected lesions, 18 (30 %) were identified with second-look sonography using conventional B-mode alone, whereas 60 (90 %) lesions were detected with second-look sonography using RVS (p < 0.001). The detection rates of 16 focal lesions, 46 mass lesions, 16 lesions sized <5 mm, 45 lesions sized 5–10 mm, 26 lesions situated within the mammary gland, 41 lesions situated around mammary fascia, 24 malignant lesions, and 43 benign lesions were, respectively, 25, 26, 25, 24, 42, 17, 33, and 23 % by conventional B-mode, and were significantly higher, respectively, at 94, 89, 94, 89, 88, 90, 92, and 88 % by RVS. Of the seven lesions with no sonographic correlates, five could be biopsied by marking MRI information onto the body surface using RVS. Overall, 65 of 67 (97 %) MRI-detected lesions were confirmed by histopathological results. Our results suggest that the additional use of RVS on second-look sonography significantly increases the sonographic detection rate of MRI-detected lesions without operator dependence.

Available only for authorised users

Morris EA et al (2003) MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 181(3):619–626PubMed

Kuhl CK et al (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23(33):8469–8476PubMedCrossRef

Warner E et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292(11):1317–1325PubMedCrossRef

Saslow D et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75–89PubMedCrossRef

Berg WA et al (2004) Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233(3):830–849PubMedCrossRef

Liberman L et al (2003) MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 180(2):333–341PubMed

Houssami N et al (2008) Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 26(19):3248–3258PubMedCrossRef

LaTrenta LR et al (2003) Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. Radiology 227(3):856–861PubMedCrossRef

Teifke A et al (2003) Outcome analysis and rational management of enhancing lesions incidentally detected on contrast-enhanced MRI of the breast. AJR Am J Roentgenol 181(3):655–662PubMed

10.

Beran L et al (2005) Correlation of targeted ultrasound with magnetic resonance imaging abnormalities of the breast. Am J Surg 190(4):592–594PubMedCrossRef

11.

Linda A et al (2008) Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size. Breast 17(1):51–57PubMedCrossRef

12.

Shin JH et al (2007) Targeted ultrasound for MR-detected lesions in breast cancer patients. Korean J Radiol 8(6):475–483PubMedCrossRef

13.

Demartini WB et al (2009) Utility of targeted sonography for breast lesions that were suspicious on MRI. AJR Am J Roentgenol 192(4):1128–1134PubMedCrossRef

14.

Destounis S et al (2009) Community-based practice experience of unsuspected breast magnetic resonance imaging abnormalities evaluated with second-look sonography. J Ultrasound Med 28(10):1337–1346PubMed

15.

Meissnitzer M et al (2009) Targeted ultrasound of the breast in women with abnormal MRI findings for whom biopsy has been recommended. AJR Am J Roentgenol 193(4):1025–1029PubMedCrossRef

16.

Nakano S et al (2009) Fusion of MRI and sonography image for breast cancer evaluation using real-time virtual sonography with magnetic navigation: first experience. Jpn J Clin Oncol 39(9):552–559PubMedCrossRef

17.

Abe H et al (2010) MR-directed (“Second-Look”) ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings. AJR Am J Roentgenol 194(2):370–377PubMedCrossRef

18.

Carbognin G et al (2010) Utility of second-look ultrasound in the management of incidental enhancing lesions detected by breast MR imaging. Radiol Med 115(8):1234–1245PubMedCrossRef

19.

Candelaria R et al (2011) Second-look US examination of MR-detected breast lesions. J Clin Ultrasound 39(3):115–121PubMedCrossRef

20.

Berg WA et al (2006) Operator dependence of physician-performed whole-breast US: lesion detection and characterization. Radiology 241(2):355–365PubMedCrossRef

21.

Nakano S et al (2007) Detection of enhancing lesions on contrast-enhanced MRI of the breast using real-time virtual sonography; fusion of MRI and sonography data. Breast Cancer Res Treat 106:S13 (abstr 43)

22.

Nakano S et al (2012) Real-time virtual sonography, a coordinated sonography and MRI system that uses magnetic navigation, improves the sonographic identification of enhancing lesions on breast MRI. Ultrasound Med Biol 38(1):42–49PubMedCrossRef

23.

Yamamoto S et al (2010) Sentinel lymph node detection in breast cancer patients by real-time virtual sonography constructed with three-dimensional computed tomography–lymphography. Breast J 16(1):4–8PubMedCrossRef

24.

Yamamoto S et al (2012) Prospective ultrasonographic prediction of sentinel lymph node metastasis by real-time virtual sonography constructed with three-dimensional computed tomography–lymphography in breast cancer patients. Breast Cancer 19(1):77–82PubMedCrossRef

25.

D’Orsi C et al (2003) Breast imaging reporting and data system: ACR BIRADS—breast imaging atlas. American College of Radiology, Reston

26.

Peters NH et al (2008) Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 246(1):116–124PubMedCrossRef

27.

Stacey-Clear A et al (1993) Mammographically detected breast cancer: location in women under 50 years old. Radiology 186(3):677–680PubMed

28.

Stavros AT et al (1995) Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 196(1):123–134PubMed

29.

Tozaki M et al (2006) Supine MR mammography using VIBE with parallel acquisition technique for the planning of breast-conserving surgery: clinical feasibility. Breast 15(1):137–140PubMedCrossRef

30.

Sakakibara M et al (2008) Breast-conserving surgery using projection and reproduction techniques of surgical-position breast MRI in patients with ductal carcinoma in situ of the breast. J Am Coll Surg 207(1):62–68PubMedCrossRef

31.

Nakamura R et al (2008) Breast-conserving surgery using supine magnetic resonance imaging in breast cancer patients receiving neoadjuvant chemotherapy. Breast 17(3):245–251PubMedCrossRef

32.

Rizzatto G et al (2009) Breast imaging and volume navigation: MR imaging and ultrasound coregistration. Ultrasound Clin 4:261–271CrossRef

33.

Alderliesten T et al (2011) On the feasibility of MRI-guided navigation to demarcate breast cancer for breast-conserving surgery. Med Phys 37(6):2617–2626CrossRef

34.

Siegler P et al (2011) Supine breast MRI. J Magn Reson Imaging 34(5):1212–1217PubMedCrossRef

35.

Fausto A et al (2012) A new method to combine contrast-enhanced magnetic resonance imaging during live ultrasound of the breast using volume navigation technique: A study for evaluating feasibility, accuracy and reproducibility in healthy volunteers. Eur J Radiol 81(3):332–337

Title: Impact of real-time virtual sonography, a coordinated sonography and MRI system that uses an image fusion technique, on the sonographic evaluation of MRI-detected lesions of the breast in second-look sonography
Authors: Shogo Nakano
Junko Kousaka
Kimihito Fujii
Kyoko Yorozuya
Miwa Yoshida
Yukako Mouri
Miwa Akizuki
Rie Tetsuka
Takahito Ando
Takashi Fukutomi
Yukihiko Oshima
Junko Kimura
Tsuneo Ishiguchi
Osamu Arai
Publication date: 01-08-2012
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 3/2012
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-012-2163-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2012

Mutational analysis of telomere genes in BRCA1/2-negative breast cancer families with very short telomeres

A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer

Atypical ezrin localization as a marker of locally advanced breast cancer

Strigolactones: a novel class of phytohormones that inhibit the growth and survival of breast cancer cells and breast cancer stem-like enriched mammosphere cells

Lipid profiles within the SABRE trial of anastrozole with and without risedronate

The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivors

Keynote webinar | Spotlight on antibody–drug conjugates in cancer